Medical Mycology · 1986 · 42 citations · 8 references
MedicineMicrobiologyPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceAntifungal AgentsAntifungal PharmacologyAntifungal ResistanceAntifungal TherapyAntimicrobial Drug InteractionsAntimicrobial Susceptibility TestingAntifungal AntibioticsAzole Antifungal InteractionsAzole FungicidesAzole ResistanceEukaryotic Ribosome FunctionFungal AntibioticsGrowth In Complex MediaNew Antifungal Agents
Low, reproducible minimal inhibitory concentrations against Candida species, with sharp, precise end points in complex media were achieved for imidazoles (clotrimazole, econazole, miconazole, tioconazole and ketoconazole) and triazoles (fluconazole, itraconazole, vibunazole, ICI 153066) by including in the test medium antibacterial antibiotics that bind to the 80S eukaryotic ribosome and inhibit protein synthesis, i.e. blasticidin, cycloheximide, doxycycline, neomycin and gentamicin. The presence of these antibiotics reduced MICs, on average, by 50- to 250-fold. Other protein synthesis inhibitors (rifampicin, erythromycin, lincomycin, clindamycin, chloramphenicol and fusidic acid) were not effective, and the antibiotics did not affect MICs for Aspergillus species. The low azole MICs were in close agreement with MICs obtained in a defined, tissue culture-based medium lacking added antibiotics.
8
Current Therapeutic Research · 2003 · 154 citations · Full text
Marcia R. Moody, Viola Maye Young, Margaret J. Morris et al. · Antimicrobial Agents and Chemotherapy · 1980 · 35 citations · Full text